Zoetis Inc. (NYSE:ZTS) Holdings Lifted by New England Research & Management Inc.

New England Research & Management Inc. increased its holdings in Zoetis Inc. (NYSE:ZTS) by 7.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,943 shares of the company’s stock after purchasing an additional 1,775 shares during the period. Zoetis accounts for 2.1% of New England Research & Management Inc.’s holdings, making the stock its 7th biggest holding. New England Research & Management Inc.’s holdings in Zoetis were worth $4,064,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new stake in Zoetis in the 3rd quarter worth approximately $31,000. First Personal Financial Services bought a new position in shares of Zoetis during the 3rd quarter valued at approximately $33,000. Capital Performance Advisors LLP purchased a new position in Zoetis during the 3rd quarter valued at $33,000. Dunhill Financial LLC boosted its holdings in Zoetis by 80.6% during the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after acquiring an additional 75 shares during the period. Finally, Quarry LP boosted its holdings in Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after acquiring an additional 153 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. UBS Group assumed coverage on Zoetis in a report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective for the company. Stifel Nicolaus lowered their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Morgan Stanley lowered their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating for the company in a report on Wednesday. Leerink Partners started coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price for the company. Finally, Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $215.00.

Zoetis Trading Down 0.1 %

Shares of NYSE ZTS opened at $170.33 on Thursday. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The stock has a market capitalization of $76.85 billion, a P/E ratio of 32.02, a price-to-earnings-growth ratio of 2.57 and a beta of 0.89. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $200.53. The business has a fifty day moving average price of $169.93 and a 200 day moving average price of $179.65.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same period in the prior year, the business posted $1.36 EPS. The firm’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts expect that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend is Tuesday, January 21st. Zoetis’s dividend payout ratio is currently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.